+761.7%
COST vs THC
+1,458.3%
-696.6%
-31.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.8% | -0.2% | +0.9% | +0.8% |
| 7D | -0.4% | -8.0% | +7.6% | +0.3% |
| 30D | +10.6% | -2.2% | +12.8% | +10.7% |
| 3M | +18.2% | -3.5% | +21.7% | +18.5% |
| 6M | +2.9% | +40.4% | -37.5% | -0.1% |
| YTD | +28.6% | +32.4% | -3.9% | +25.0% |
| 1Y | +24.1% | +41.0% | -16.9% | +20.0% |
| 3Y | +97.4% | +305.2% | -207.8% | +73.9% |
| 5Y | +117.8% | +239.8% | -122.0% | +91.1% |
| All | +761.7% | +1,458.3% | -696.6% | +601.0% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling